Eagle Global Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,682
Closed -$298K 230
2023
Q1
$298K Sell
12,682
-147
-1% -$3.95K 0.02% 191
2022
Q4
$358K Sell
12,829
-414
-3% -$10.6K 0.02% 178
2022
Q3
$310K Sell
13,243
-213
-2% -$6.43K 0.02% 187
2022
Q2
$454K Sell
13,456
-349
-3% -$12.2K 0.03% 165
2022
Q1
$482K Sell
13,805
-327
-2% -$11.2K 0.03% 176
2021
Q4
$430K Sell
14,132
-932
-6% -$30.4K 0.03% 184
2021
Q3
$494K Sell
15,064
-1,071
-7% -$34.3K 0.03% 169
2021
Q2
$488K Buy
+16,135
New +$531K 0.03% 181

Other funds holding OGN

Eagle Global Advisors's OGN Position: Q2 2023 in Review

Eagle Global Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 12,682 shares — an estimated $298K sold.

Eagle Global Advisors first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $494K in Q3 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Eagle Global Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Eagle Global Advisors sold 12,682 Organon & Co shares in Q2 2023, an estimated $298K.
  • Eagle Global Advisors first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Eagle Global Advisors's Organon & Co position peaked at $494K in Q3 2021.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Eagle Global Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.